Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation

Spronk, H.M.H.; Jong, A.M. de; Verheule, S.; Boer, H.C. de; Maass, A.H.; Lau, D.H.; ... ; Schotten, U. (2017)

Article / Letter to editor

• Atrial fibrillation
• Hypercoagulability
• Stroke
• Protease-activated receptors
• Direct thrombin inhibitors
• Atrial fibrosis

• All authors: Spronk, H.M.H.; Jong, A.M. de; Verheule, S.; Boer, H.C. de; Maass, A.H.; Lau, D.H.; Rienstra, M.; Hunnik, A. van; Kuiper, M.; Lumeij, S.; Zeemering, S.; Linz, D.; Kamphuisen, P.W.; Cate, H. ten; Crijns, H.J.; Gelder, I.C. van; Zonneveld, A.J. van; Schotten, U.
• Date: 2017-01-01
• Journal: European Heart Journal
• Volume: 38
• Issue: 1
• Pages: 38 - 50
• DOI: doi:10.1093/eurheartj/ehw119